Prices Were Rising On COVID-19 Drug Prospects Before Trials Began

By John Wilkerson / April 16, 2020 at 3:28 PM

Prices for a handful of COVID-19 drug candidates started to rise before researchers began testing them as COVID-19 treatments, according to 46Brooklyn, and that does not bode well for controlling prices of drugs if tests show they work against the coronavirus.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.